Treatment of COPD with inhaled corticosteroids (ICS) may decrease the risk of dying from pneumonia and from other causes despite being associated with an increase in the occurrence of pneumonia, ...
ICS are commonly used in bronchiectasis patients, despite guidelines advising against it unless specific conditions are present. The study found ICS users with elevated eosinophils had fewer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results